Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
DaxibotulinumtoxinA by Revance Therapeutics for Upper Limb Muscle Spasticity: Likelihood of Approval
DaxibotulinumtoxinA is under clinical development by Revance Therapeutics and currently in Phase II for Upper Limb Muscle Spasticity. According to...